US OptionsDetailed Quotes
NVO240913C150000
- 0.03
- -0.03-50.00%
15min DelayClose Sep 10 16:00 ET
0.03High0.03Low
0.03Open0.06Pre Close34 Volume90 Open Interest150.00Strike Price102.00Turnover71.45%IV15.60%PremiumSep 13, 2024Expiry Date0.00Intrinsic Value100Multiplier3DDays to Expiry0.03Extrinsic Value100Contract SizeAmericanOptions Type0.0139Delta0.0042Gamma3244.50Leverage Ratio-0.0332Theta0.0001Rho44.95Eff Leverage0.0042Vega
Novo-Nordisk A/S Stock Discussion
Sign in to post a comment
Alright, I gotta say it: the hype around Ozempic, Wegovy, and other weight loss drugs is getting out of hand. Sure, stocks like Lily and Novo are hot now, but I don’t think that’ll last.
Think about it—30-40 years ago, there were hardly any overweight people. Look at any old photos from the ‘80s. Nowadays, it feels like everyone’s struggling with weight. What changed? It’s all those seed oils, artificial flavors, gums, and additiv...
Think about it—30-40 years ago, there were hardly any overweight people. Look at any old photos from the ‘80s. Nowadays, it feels like everyone’s struggling with weight. What changed? It’s all those seed oils, artificial flavors, gums, and additiv...
5
4
$Novo-Nordisk A/S (NVO.US)$ what the hell, washing plate
Argument:
The upcoming interest rate cuts are poised to benefit the biotech stock industry, setting the stage for strong performance in the coming quarters.
Reasons:
Cheaper Funding: Lower interest rates make it easier for biotech companies to access capital for research and development, accelerating their progress and growth potential.
Attractive Valuations: Biotech stocks are currently trading at attractive levels, offering investors an opportunity to capitalize on the sector's long-term pot...
The upcoming interest rate cuts are poised to benefit the biotech stock industry, setting the stage for strong performance in the coming quarters.
Reasons:
Cheaper Funding: Lower interest rates make it easier for biotech companies to access capital for research and development, accelerating their progress and growth potential.
Attractive Valuations: Biotech stocks are currently trading at attractive levels, offering investors an opportunity to capitalize on the sector's long-term pot...
5
1
Last night's sell-off was so bad. Wiping some of the gains if you follow my last post. I believe the direction of the market today will all be tied to Powell's speech.
$Tesla (TSLA.US)$ closed lowest point of the week yesterday. One of the biggest drops among my portfolio. I am waiting for more positive news from Robotaxi announcement scheduled on Oct 10
I am also holding on to $NVIDIA (NVDA.US)$ as the earnings approaching next week, holding my view th...
$Tesla (TSLA.US)$ closed lowest point of the week yesterday. One of the biggest drops among my portfolio. I am waiting for more positive news from Robotaxi announcement scheduled on Oct 10
I am also holding on to $NVIDIA (NVDA.US)$ as the earnings approaching next week, holding my view th...
18
3
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Market finally pullback after a long run. Is it a healthy pullback? I think it is. Of course, all eyes and ears are on Jackson Hole waiting for Powell to speak. We will see.
$Advanced Micro Devices (AMD.US)$ $NVIDIA (NVDA.US)$ $Novo-Nordisk A/S (NVO.US)$ $S&P 500 Index (.SPX.US)$
$Advanced Micro Devices (AMD.US)$ $NVIDIA (NVDA.US)$ $Novo-Nordisk A/S (NVO.US)$ $S&P 500 Index (.SPX.US)$
6
10
1. $Amazon (AMZN.US)$ | E-Commerce & Cloud
• Amazon's unmatched logistics network is nearly impossible to replicate, and AWS continues to reign as the king of cloud computing, set to accelerate further with the AI explosion.
2. $Microsoft (MSFT.US)$ | Cloud & AI
• They are poised to redefine productivity & enterprise solutions, becoming the definitive platform for cloud computing and AI integration across global...
• Amazon's unmatched logistics network is nearly impossible to replicate, and AWS continues to reign as the king of cloud computing, set to accelerate further with the AI explosion.
2. $Microsoft (MSFT.US)$ | Cloud & AI
• They are poised to redefine productivity & enterprise solutions, becoming the definitive platform for cloud computing and AI integration across global...
36
This is my current portfolio, coming out of last weeks correction and volatility. it's been doing reasonably well, and is currently over-performing QQQ, which is a start.
Of those not listed I'm holding $Palantir (PLTR.US)$, $Serve Robotics (SERV.US)$, $CrowdStrike (CRWD.US)$, $Novo-Nordisk A/S (NVO.US)$ and some fixed income ETFs.
Does anyone have any recommendations for other positions which have some fairly obvious ground to cover during their recovery?
Also, what are your thou...
Of those not listed I'm holding $Palantir (PLTR.US)$, $Serve Robotics (SERV.US)$, $CrowdStrike (CRWD.US)$, $Novo-Nordisk A/S (NVO.US)$ and some fixed income ETFs.
Does anyone have any recommendations for other positions which have some fairly obvious ground to cover during their recovery?
Also, what are your thou...
17
5
$Novo-Nordisk A/S (NVO.US)$ please keep going up,,,😘
2
2
Good morning, traders. Happy Friday, it's nearly afternoon and a tropical storm is coming to Jersey city. The market is turbulent and trying to not fall after the S&P 500 hit its best day for the year on Thursday. Monday was the worst trading day for the S&P 500 in two years.
My name is Kevin Travers, here are moovin' stonks.
Eli Lilly $Eli Lilly and Co (LLY.US)$ climbed a further 7% Friday after a Thursday Q2 earnings beat, boo...
My name is Kevin Travers, here are moovin' stonks.
Eli Lilly $Eli Lilly and Co (LLY.US)$ climbed a further 7% Friday after a Thursday Q2 earnings beat, boo...
45
5
$Novo-Nordisk A/S (NVO.US)$ how does this guy keeps going up when Eli Lilly was the one beating earnings.
2
1
No comment yet
MonkeyGee : if you need a pill to lose weight, you have other issues.
Learning_Piggy : I used to think this way until I looked around and see more than a few obese people never managed to get out of obesity by themselves.
With or without surgery, with or without dietary restriction, obesity will most likely come back to them and it takes more than just personal grit to fight it.
InfiltradeR Learning_Piggy : Let's not forget the ever rising diabetes numbers.
Learning_Piggy InfiltradeR : exactly！